Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 19, 2022
The impact of antibodies to other coronaviruses on risk of SARS-CoV-2 infection in mothers and infants
From the Lehman and Overbaugh Labs, Human Biology Division
Gone but not lost: a computational method to infer missing data measurements
From Tal Einav of the Bloom Lab, Basic Sciences Division
A bit of hit and miss – how well antibody responses in pre-clinical models resemble human responses
From the Overbaugh Lab, part of the Human Biology Division
Antibody, how do I escape thee? Let me count the ways.
From the Bloom Lab, Basic Sciences and Public Health Sciences Divisions
Natural protection from COVID-19 gets boost from a single dose of vaccine
Tests of patients' blood show vaccine stirs antibodies against variants and 2003 SARS virus
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
Antibodies a hot topic in COVID-19 research
Hutch scientists tap their antibody expertise for new tests, treatments, vaccines
Studying the complex interactions between antibodies and viral targets
Bloom Lab postdoc Dr. Tal Einav named Damon Runyon Quantitative Biology Fellow
Wild-type vs. modification: which is better?
From Stamatatos Laboratory, Vaccine and Infectious Disease Division
To protect, or to enhance? That is the question for Dengue virus antibodies
From Dr. Halloran, Vaccine and Infectious Disease Division
Thai HIV vaccine trial follow-up studies offer possible explanation for HIV prevention success
Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies
HIV 'superinfection' boosts immune response
Overbaugh, Cortez-led study shows women infected by two different HIV strains exhibit strong antibody response; findings may aid vaccine development
Study finds HIV ‘superinfection’ boosts immune response
Findings may provide insight into HIV-vaccine development
American Society for Microbiology lauds Blish
HIV research garners early career award
An 'HIV-test' equivalent for early detection of lung cancer
New cancer-screening strategy uses the immune system to signal early signs of disease
Antibody-Targeted Chemotherapy with Mylotarg Shows Promise for Many Adults with Deadly Form of Leukemia
Fred Hutchinson Cancer Research Center Researcher Presents Updated Study Results at the American Society of Clinical Oncology Meeting in New Orleans